Echo Therapeutics (ECTE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2012 | 09-2012 | 06-2012 | 03-2012 | 12-2011 | |
| Sales | -88 | 31 | 31 | 31 | 104 |
| Gross Profit | -88 | 31 | 31 | 31 | 104 |
| Operating Expenses | 4,611 | 3,648 | 3,535 | 3,251 | 2,721 |
| Operating Income | -4,699 | -3,617 | -3,504 | -3,220 | -2,617 |
| Interest Expense | 711 | 249 | 0 | 0 | 0 |
| Other Income | 3,483 | -399 | 350 | 235 | 498 |
| Pre-tax Income | -1,927 | -4,265 | -3,154 | -2,986 | -2,119 |
| Net Income Continuous | -1,927 | -4,265 | -3,154 | -2,986 | -2,119 |
| Net Income | $-1,927 | $-4,265 | $-3,154 | $-2,986 | $-2,119 |
| EPS Basic Total Ops | -1.16 | -1.07 | -0.81 | -0.08 | -1.89 |
| EPS Basic Continuous Ops | -1.17 | -1.07 | -0.81 | -0.08 | -0.55 |
| EPS Diluted Total Ops | -1.16 | -1.07 | -0.81 | -0.08 | -1.89 |
| EPS Diluted Continuous Ops | -1.17 | -1.07 | -0.81 | -0.08 | -0.55 |
| EBITDA(a) | $-4,172 | $-3,498 | $-3,481 | $-3,200 | $-2,599 |